Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BDX > SEC Filings for BDX > Form 8-K on 5-Feb-2013All Recent SEC Filings

Show all filings for BECTON DICKINSON & CO | Request a Trial to NEW EDGAR Online Pro

Form 8-K for BECTON DICKINSON & CO


5-Feb-2013

Results of Operations and Financial Condition, Financial Statements and Exh


ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On February 5, 2013, Becton, Dickinson and Company ("BD") issued a press release announcing its financial results for its first fiscal quarter ending December 31, 2012. A copy of the press release is furnished as Exhibit 99.1 to this report.

The press release furnished as Exhibit 99.1 contains certain financial measures that differ from those presented in accordance with U.S. generally accepted accounting principles ("non-GAAP measures"), as follows:

• Revenues. We present international and total revenue growth rates (for the total company and each of its segments and units, and for our safety-engineered devices) after eliminating the effect of foreign currency translation. We believe that these measures of revenue growth allow investors to better understand the underlying operating results of BD and facilitate comparisons to prior periods.

• Earnings Per Share from Continuing Operations. We present our EPS growth for the first quarter of fiscal year 2013 after eliminating the effect of foreign currency translation. We believe that eliminating the effect of foreign currency translation allows investors to better understand the underlying operating results of BD and facilitates comparisons to prior periods.

We also present estimated EPS guidance for fiscal year 2013 after eliminating the estimated impact of foreign currency translation during the fiscal year and the estimated impact of the medical device excise tax that has gone into effect during the year under the U.S. healthcare reform law. Eliminating the effect of foreign currency translation allows investors to better understand the anticipated underlying performance of BD and assess BD's earnings guidance relative to prior periods. Eliminating the impact of the medical device excise tax also allows investors to compare BD's 2013 guidance to prior periods as the tax is in effect for the first time in 2013.

We also present estimated EPS growth rates for fiscal year 2013 after adjusting fiscal year 2012 EPS by excluding the pension settlement charge recorded in the fourth quarter of fiscal year 2012. This charge is not considered by management to be part of ordinary operations, and management believes eliminating this charge when providing fiscal year 2013 EPS guidance allows investors to better understand our guidance in relation to fiscal year 2012.




ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit 99.1 Press release dated February 5, 2013, which is furnished pursuant to Item 2.02


  Add BDX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BDX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.